Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Wegovy a day early is not recommended. Semaglutide is designed as a once-weekly injection on a consistent schedule, and shifting that schedule without clinical guidance can affect how your body tolerates the medicine and how steady the active dose stays in your system. Here is what the evidence and prescribing guidance actually say, and what to do if your usual injection day is not going to work.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is easy to think of a weekly injection as roughly weekly rather than precisely weekly. You have a busy Monday, the pen is in the fridge, and Tuesday feels close enough. That logic is understandable, and the flexibility question is one our prescribers hear regularly.
The reality is more specific. Semaglutide accumulates in the body over several weeks before reaching a steady concentration. Once you are at that steady level, the roughly seven-day gap between injections is part of how the medicine is designed to behave. The NHS medicines information for semaglutide states clearly that Wegovy should be taken on the same day each week. The Patient Information Leaflet gives one exception: if you have genuinely missed a dose, you may take it within five days of the missed date, then return to your regular day. That clause exists for missed doses, not for bringing a dose forward because the diary is full.
Taking the injection a day early is not the same as missing a dose, and our page on what happens when you take Wegovy a day early explains why that distinction matters clinically. It compresses the gap between two active doses. Because semaglutide's half-life is approximately one week, an earlier second injection means more overlap with the tail of the previous one, which can push nausea, vomiting and other gastrointestinal effects higher than you would otherwise expect.
The practical risk is not a medical emergency in most cases, but it is real. Gastrointestinal side effects (nausea, loose stools, reflux, stomach cramping) are the most common reasons people pause or discontinue semaglutide treatment. Most people find these effects are worst in the first days after a new dose or a dose increase; they tend to settle as the week goes on. Taking the next injection before that settling has finished can restart or intensify the effect.
Over time, if you keep drifting earlier each week, the effective dose interval shortens and the cumulative side-effect burden rises. That matters most at higher doses, particularly once you are on 1.7mg or 2.4mg maintenance. There is also a practical consideration around how much Wegovy costs over the course of treatment: running through pens faster than prescribed adds up and brings prescription renewals forward without any clinical review of whether the timing change is appropriate.
If you are considering taking semaglutide a day early because your lifestyle requires a different weekly day, that is solvable, and our guide to flow semaglutide explains how a well-structured dosing schedule is designed to work around real life. It just needs to be done with a prescriber's input rather than quietly adjusted at home.
The correct route to a new injection day is a conversation with whoever prescribes your treatment. A prescriber can map out a safe transition, often by lengthening one interval slightly rather than shortening it, so that the new weekly day is established without stacking doses.
At nume, every repeat order goes through a same-day clinical review by a GPhC-registered prescriber before anything is dispensed. That review is the right moment to flag a timing question, including if you are wondering whether you can take Wegovy one day early on a one-off basis. You can reach our team any day of the week through our support line, or read through common prescribing questions before you get in touch.
For broader context on how semaglutide works and what to expect week by week, the Wegovy overview on this site covers the full licensed schedule in plain language. The semaglutide information page goes deeper on mechanism and trial evidence if you want the clinical picture. And if you are weighing up whether this treatment suits your situation at all, our weight-loss treatment guide sets out the options clearly.
Life interrupts schedules. A genuine clash (travel, a procedure, an event where nausea would be badly timed) is different from a habit of early dosing. The Patient Information Leaflet permits taking a delayed dose up to five days after your usual day, then returning to the original schedule. It does not permit moving a dose earlier to make room in the calendar.
If your usual day genuinely no longer works as a permanent fixture, the solution is a planned day-change with prescriber guidance, not unilateral early injection. A short message to your clinical team is all it takes to get a safe plan. That is not an unusual request, and a good prescriber will have a clear answer ready.
If you are not yet on treatment and are thinking about whether Wegovy is right for you, check your eligibility with a free consultation and speak to our prescribers about the schedule that would fit your routine from the start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.